Translational Haematology
Our Translational Hematology group was created with the aim of generating knowledge in the field of hematology and collaborating with other groups for the implementation of projects. Our activity is based on a broad portfolio of clinical trials, basic research projects and registry studies. The area of knowledge in which we focus is the study of the immune system and its relationship with oncohematological diseases and their infectious complications, cell therapy, study of the adverse effects of drugs and optimization in obtaining and using blood components in Transfusion Therapy.
Search for publications
Only original articles, editorials, guidelines.
-
Lloret-Madrid P, Rodríguez-Veiga R, Bergua JM, Algarra JLA, Botella C, Rodríguez-Arbolí E, Bernal T, Tormo M, Calbacho M, Salamero O, Serrano J, Noriega V, López-López JA, Vives S, López-Lorenzo JL, Colorado M, Vidriales MB, Boyero RG, Olave MT, Herrera P, Arce O, Barrios M, Sayas MJ, Polo M, Gómez-Roncero MI, Barragán E, Ayala R, Chillón C, Calasanz MJ, Paiva B, Boluda B, Casas-Avilés I, Sánchez MJ, Rodríguez-Medina C, Cuevas L, Raposo-Puglia JÁ, Mateos MC, Olivares M, Martínez-Chamorro C, Alonso N, Suárez S, Sánchez-Vadillo I, Rodríguez MS, González BJ, Martínez-Francés A, Cuello R, Fernández A, Martínez-Cuadrón D, Labrador J, Montesinos P.
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.
HAEMATOLOGICA . : .
-
Gonzalez C, Guerrero C, Larrayoz M, Zabaleta A, Zhao J, Kostopoulos IV, Tsitsilonis O, Terpos E, Gutierrez NC, Fernandez M, Calasanz MJJ, Rodriguez-Otero P, Prosper F, Lozano T, Lasarte JJ, Ebert BL, Oriol A, Sureda A, Blanchard MJ, González-Montes Y, Bargay J, Lakhwani S, Ríos-Tamayo R, Rosiñol L, Martínez-López J, Lahuerta JJ, Bladé J, Mateos MV, San-Miguel J, Cedena MT, Puig N, Hagner PR, Ortiz Estevez M, Martínez-Climent JA, Paiva B.
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.
BLOOD . : .
-
Guijarro-Martínez P, Sánchez-Cuervo M, Parro-Martín MÁ, Gómez Bayona E, Luna de Abia A, Chinea Rodríguez A, Herrera Puente P, Hinojo Marín B, Nova Ruiz G, López Jiménez J, Martín-Aragón S, Álvarez-Díaz AM.
Comprehensive PHARmaceutical care programme in patients undergoing ALLOgeneic haematopoietic stem cell transplantation (PHARALLO): protocol for a prospective interventional study with a historical control group.
European Journal of Hospital Pharmacy . : . Number of citations: 1
-
Rodríguez-Arbolí E, Soria-Saldise E, Barragan E, Ayala R, Sánchez-García J, Bilbao-Sieyro C, Chillon MC, Larrayoz MJ, Hillebrand P, Bernal Del Castillo T, Bergua Burgues JM, Botella C, Tormo M, Algarra L, Colmenares R, Serrano J, García-Fortes M, Balerdi A, Alonso-Domínguez JM, Rodríguez-Medina C, García Perez MJ, Hermosín L, Sanchez Vadillo I, Fernández Martín R, Oliva Hernandez A, García-Boyero R, Ibañez-Alis F, Colorado M, Raposo-Puglia JÁ, Lacalzada Higueras C, Noriega V, Herrera P, Abuin Blanco A, Solé-Rodríguez M, Vidriales MB, Labrador J, Gómez-García LM, García Garay MDC, Lopez-Lopez JA, Arce-Fernández O, Olave T, Pérez Santaolalla E, Sargas C, Martínez-López J Sr, Prados de la Torre E, Gomez Casares MT, Gutierrez NC, Calasanz MJ, Pérez-Simón JA, Montesinos P.
Genomic and clinical landscape of RAS mutations in acute myeloid leukemia.
BLOOD . : .
-
Kuykendall AT, Bankar A, Pettit KM, Shatzel J, Lucchesi A, García-Gutiérrez V, Mayer J, Yacoub A, Gill H, Sasca D, Scandura JM, Kremyanskaya M, Ross DM, Palandri F, Fox ML, Vannucchi AM, Haque T, Koschmieder S, Kiladjian JJ, Oyuela P, Dinh P, Xiao J, Valone FH, Gupta S, Khanna S, Molina A, Pemmaraju N.
VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.
JOURNAL OF CLINICAL ONCOLOGY . : .
-
Paiva B, Burgos L, Gonzalez C, Ahdadi A, Rodriguez-Veiga R, Solana-Altabella A, Lloret-Madrid P, Acuña-Cruz E, Gil C, Botella C, Rodriguez-Arboli E, Caballero Velazquez T, Bernal T, Cedena T, Herrera P, Sossa CL, Serrano J, Sanchez J, Lopez JL, Vidriales B, Tormo M, Romero MA, Colorado M, Benavente C, Bergua JM, Perez-Encinas M, Algarra L, Rodriguez-Medina C, Fiallo-Suárez D, Garcia-Boyero R, Casado LF, Labrador J, Barrios M, de Rueda B, Espinoza M, Sayas MJ, Cuervo DM, Amigo ML, Mariz JM, Giovanna Gomez K, Couto C, Perez E, Almela A, Viñas-Noguera J, Lavilla-Rubira E, Arce O, Olave M, Lopez M, Madrigal MD, Gomez LM, Grille S, Hidalgo S, Garcia D, Garcia MJ, Martinez C, Salamero O, Sempere A, Martin-Herreros B, Mena AV, Martinez-Cuadron D, Montesinos P.
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.
LEUKEMIA . : .
-
Gabarros-Subira M, Pomares H, Beas F, Torres-Esquius S, López-Esteban M, Hernández-Sánchez A, Lopez-Fernandez E, Ramil G, Hermosín L, Carreño-Tarragona G, Gomez-Garcia de Soria V, Martín I, Dominguez-Garcia JJ, Santiago M, Pascual-Cascón MJ, Díaz-Beyá M, Bautista G, Chen-Liang TH, Ortuño Giner F, Gener-Ricos G, Palomo L, Garcia-Maño L, Gómez Casares MT, Bilbao-Sieyro C, Alfonso-Pierola A, Piris-Villaespesa M, Revilla N, Alonso-Alvarez S, Iborra A, Ferrer-Lores B, López-Corral L, Pratcorona M, Balsalobre P, Balbastre-Úbeda F, Orti G, Mussetti A, Ayala R, Buno I, Cervera J, Díez-Campelo M, Río-Machín A, Montoro MJ, Zamora L, Tormo M, Bosch F, Hernández Mohedo F, Arnan M, Valcarcel D, Martinez-Laperche C, Jerez A.
Molecular Underpinnings and Prevalence of Donor Cell-Derived Hematologic Neoplasms among Spanish Transplantation Centers.
BLOOD . : .